NATIONAL BIOTECHNOLOGY DEVELOPMENT AGENCY (ESTABLISHMENT) ACT, 2022
Section 4: Cessation of office.
(1) Notwithstanding the provisions of section 3, a member of the Board ceases to hold office if he-
(a) resigns his appointment by notice under his hand addressed to the President;
(b) becomes of unsound mind;
(c) becomes bankrupt or makes a compromise with his creditors;
(d) is convicted of a felony or of any offence involving dishonesty or corruption; and
(e) becomes incapable of carrying out the functions of his office, either arising from an infirmity of mind or body or any other cause.
(2) Where the President is satisfied that it is not in the interest of the Agency or the public for a member to continue in office, the President may remove that member from the Board.
(3) Where a vacancy occurs in the membership of the Board, it shall be filled by the appointment of a successor to hold office for the remainder of the term of office of his predecessor and the successor shall represent the same interest as his predecessor.
Cite this section
Section 4, NATIONAL BIOTECHNOLOGY DEVELOPMENT AGENCY (ESTABLISHMENT) ACT, 2022 (2022).
https://repo.podus.ai/laws/national-biotechnology-development-agency-establishment-act-2022/section/4/